JCU - Abstracts of the BAUS 2018 Scientific Meeting - June 2018 - 73

Abstracts
Methods: Patients presenting from January to December
2016 were identified from prospectively collected emergency and elective databases. Catheterised patients over
80 years with >300mls residual volumes who were refractory to medical treatment and those with high pressure
chronic retention were included.
Results: 48 patients with a mean age of 86 years were
followed up for an average of 19 months. 26 patients were
treated with LTC and 22 patients underwent bipolar
trans-urethral resection of the prostate (TURP). The average hospital stay for surgery was 3.5 days. The complication rate after TURP was 45%. 19/22 were voiding at late
follow up, 2 of whom required intermittent self-catheterisation (ISC). 17/26 of the LTC group had emergency hospital admissions for urological issues, compared to 6/22 of
the surgery group (p=0.04). The mean number of days
spent in hospital due to urological issues was 20 following
LTC and 2.3 following TURP (p=0.03). 9/26 of the catheter
group died during follow up, 3 from catheter associated
urosepsis. There were 2 deaths in the surgery group, both
from metastatic prostate cancer.
Conclusion: Elderly patients who are catheterised for
CUR who undergo surgery are likely to spend significantly
less time in hospital due to urological complications than
those who are treated with long term catheters.
P8-9 3 years follow up results of MediTate®
temporary implantable nitinol device (TIND)
implantation for the BPH related bladder
outlet obstruction treatment
Popriglia F1, Amparore D1, Bertolo R1, Checcucci E1,
Fiori C1
1San Luigi Hospital, Orbassano - Turin, Italy

Objectives: To report 3 years outcomes of a prospective
study on Temporary Implantable Nitinol Device (TIND Meditate®) implantation for the treatment of lower urinary tract symptoms (LUTS).
Methods: The TIND, in its expanded configuration, exerts
radial force producing incisions of the bladder neck.
Thirty-two patients with LUTS were enrolled. Inclusion
criteria: age >50 years, IPSS scores of t10, urinary peak
flow (Qmax) < 12 ml/sec, prostate volume < 50 cc.
TIND was implanted under light sedation using a rigid
22F cystoscope and removed 5 days later in an outpatient setting.
Demographics, perioperative, functional results, complications and quality of life (QoL) were evaluated. For the purpose of this study 12, 24 and 36 months postoperatively
results are reported.
Results: Patients' mean age was 69.4 years, mean prostate volume, median IPSS score, median QoL and mean
Qmax were 29.5 cc, 19, 3, and 7.6 ml/sec respectively. No
complications were recorded during implantations and
retrievals. After 12 months, IPSS score, QoL and Qmax

73
were 9, 1 and 12 ml/sec respectively. When comparing
pre- and 1 year postoperative results were statistically different for all variables.
After 24 months IPSS score, QoL and Qmax were 10, 2,
and 13.7 ml/sec respectively, while after 36 months IPSS
score, QoL and Qmax were 12, 2 and 13 ml/sec. After 3
years, mean variation with respect to baseline conditions
in term of Qmax was +71%.
Conclusion: TIND implantation seem to be an effective
minimally-invasive option for the treatment of LUTS even
after 3 years of follow up.
P8-10 Pilot trial of a device to remotely
monitor and asses voiding
Mosli-lynch C1, Barton-Grimley D2, Vismer M2
1University College London Hospital, United Kingdom, 2OpSense
Medical Devices, London, United Kingdom

Introduction: SonoUroFlowmetry (SUF), though not as
accurate as conventional UroFlowmetry, does have the
advantage of being able to be carried out numerous times
a day in the patient's own home. Studies have shown that
SUF is approximately 70-80% accurate in estimating Qmax,
total voiding time and voided volume.
Methods: This study examines a device, invented by the
author, that records a patient's SUF curve whenever they
pass urine in their own bathroom.The data are then anonymously transmitted via a patient's smartphone or home
router to a cloud-based monitoring system where they
are analysed. The reports can be then accessed by the
patient's Urologist or Family Doctor. We examined
whether the device was able to accurately differentiate
between SUF curve and background noise- and compared
the curve to conventional UroFlowmetry.
Results: The device was successful in differentiating
between the sound of voiding and background noise, with
recording being triggered by a motion sensor. SUF accuracy when compared to conventional UroFlowmetry was
similar to previously published literature.
Conclusion: SUF has the advantages of being able to identify trends in UroDynamics as well as being carried out in a
more comfortable and familiar setting. By combining multiple
SUF curves over time, this system can build up an accurate,
'time-stamped' voiding diary that can be used by the Urologist
to direct and asses the effect of future treatments.
P8-11 Greenlight XPS laser photoselective
vapourization of prostate (PVP) in high risk
patients
Waters D1, Khalid R1, Omeire F1, Jones B1
Medical Clinic, Dublin, Ireland

1Hermitage

Introduction: Recent NICE guidance supports greenlight XPS P.V.P. as being at least as effective as TURP in

Table of Contents for the Digital Edition of JCU - Abstracts of the BAUS 2018 Scientific Meeting - June 2018